Can the RFK JR move withdraw funding for the MRNA vaccine to be a huge wrong calculation?

MRNA vaccines have been declared as a medical miracle that saved life during Covid’s pandemic, but now the United States is stepping away from their study.

US Health Secretary Robert F Kennedy, Jr., cancels $ 22 projects – worth $ 500 million (376 million British pounds) funding – to deal with infections such as Covid and Flu.

So Kennedy – probably the most famous skeptic of the vaccine in the country – makes sense or makes a monumental mistake?

Prof. Adam Finn, a vaccine researcher at the University of Bristol, says “it’s a little of both, but the MRNA excavation technology is a” stupid “and potentially” catastrophic mistake “.

Let’s cancel why.

Kennedy says he has examined the science of MRNA vaccines, concluding that “data shows that these vaccines are not effectively prevented from upper respiratory tract infections such as Covid and flu.”

Instead, he says, he will transfer the funding to “more favorable, wider vaccine platforms that remain effective even when viruses mutate.”

So are the MRNA vaccines safe? Are they effective? Will other vaccine technologies be better?

And another question is where the MRNA vaccines should fit into the pantheon of other vaccine technologies – because there are many:

• Inactivated vaccines Use the original virus or bacterium, kill it and use it to train the immune system – like the annual flu shot
• Attenuated vaccines Do not kill the infectious agent, but it makes it lighter, so it causes a slight infection – such as the vaccine against MMR (measles, mumps and rubella)
• Conjugated vaccines Use pieces of protein or sugar from a bug so that it triggers an immune response without causing infection – as for types of meningitis
• MRNA vaccines Use a fragment of a genetic code that temporarily instructs the body to make parts of a virus and the immune system responds to this

Each has advantages and disadvantages, but Prof. Finn claims that we “overdone” MRNA vaccines during the pandemic until other approaches exclude and now there is a process of correction.

“But to swing the pendulum so far that IRNNA is useless and has no value and should not develop or understand better, it is equally stupid, it did remarkable things,” he says.

The claim that MRNA vaccines do not protect against upper respiratory tract infections such as Covid and the flu “just not true,” says Prof. Andrew Polard of the Oxford Vaccines, which soon withdraws as the head of the Joint Vaccination and Immunization Committee (JCVI), which advises the government.

The vaccines have been shown to provide protection – maintaining people alive and outside the hospital – both in clinical trials and in intensive monitoring of how the vaccines performed when they were unfolded around the world.

During the first year of vaccination during the Covid pandemic, it was estimated that only Pfizer/Biontech TRNA vaccine only Nearly 6 million livesS

Against this, there were a small number of cases of heart tissue inflammation – called myocarditis – especially in young men.

“Very rare side effects need to be balanced against the enormous benefit of technology,” says Prof. Pollard.

The pandemic was an era when the world was focused on a single insidious insidious and the vaccine unfolding was intensively observed. There remains a consensus that they did extremely good than harm.

But that doesn’t mean they are the perfect technology.

MRNA vaccines Covid train the immune system to focus only one protein from the entire virus. If this protein in the coronavirus changes or mutated, then the body protection decreases.

We have seen the consequences of this – immunity is reduced and vaccines need to be updated.

One theoretical argument is that a different approach to the vaccine – such as the use of the whole virus – would give better protection, as the immune system will have more to target.

However, Prof. Pollard says that MRNA vaccines performed better than inactivated when dealing with Covid.

He says this is likely to come down to the way they are done – and the fact that the process of killing the virus also “changes viral proteins, so there is less stimulation of the immune system” than MRNA vaccines.

The need to update vaccines is not a failure of MRNA technology that can easily be resolved by rotating from one technology to another – instead it comes down to the basic nature of some viruses.

The same measles or HPV vaccines (human papilloma) have been effective for decades and show no signs of failure, since the genetic codes of the virus are more stable in any case.

But some viruses live in an eternal state of flow.

Flu, for example, is not a virus – but instead of a constantly shifting goal. At any time, a strain will be in the ascending and will most likely to create problems in the winter.

In the influenza, the inactivated influenza injection given to adults is updated every year – as is the living vaccine that is given to children as a nasal spray. The future MRNA form of the flu vaccine would work the same way.

“The question of maintaining options is for all technologies, not just MRNA,” says Prof. Pollard.

There is a legitimate scientific question about which vaccine technology is used for which disease.

What causes anxiety among scientists is that the removal of MRNA study means that we will not have these vaccines at times when we have to do what no other technology can.

Prof. Pollard says, “I do not think there is evidence that they are extremely better for protection, but where RNA Tech is streets above everything else, it responds to outbreaks.”

The world is heavily pierced by making new flu vaccines every year. But even then, there is a six -month decision -making process for the new flu strains that will be directed, growing the vaccine on a scale in chicken eggs and then distributes it. The brand new vaccines take even more time.

But with MRNA you can have the new vaccine for six to eight weeks, and then tens or hundreds of millions of doses a few months later.

Some of the projects that have withdrawn their funding in the United States have been preparing for a pandemic of bird flu. This virus, H5N1, has devastated bird populations and jumps into a wide range of other animals, including American cattle.

“It makes no sense and if we get a human pandemic of bird flu, it can be seen as a catastrophic mistake,” says Prof. Finn.

But the consequences of the United States that deviate from MRNA research can be felt broader.

What impact does this move on trust in current vaccines, MRNA or otherwise? How does it affect the world when the United States is one of the most influential countries in medical research? And will there be an effect on other types of MRNA technology, such as cancer vaccines – or using the approach to treat rare genetic diseases?

Prof. Pollard raises another question after the course of RFK JR: “Do they all our risk if a huge market turns our backs on RNA?

“This is one of the most important technologies that we will see this century in infectious diseases, biootherapeutic agents for rare diseases and critical cancer. This is a message I am worried about.”